Atlas Trials

UVB-induced Treg Cells Exert Antigen-specific Suppression Through LAG-3

Clinical trial NCT05636839 · UNKNOWN

Trial details

NCT number
NCT05636839
Sponsor
National Taiwan University Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
PsoriasisAtopic Dermatitis
Start date
2022-01-25
Primary completion
2025-12-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.